The role of mediator complex subunit 19 in human diseases.


Journal

Experimental biology and medicine (Maywood, N.J.)
ISSN: 1535-3699
Titre abrégé: Exp Biol Med (Maywood)
Pays: England
ID NLM: 100973463

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 27 5 2021
medline: 12 8 2021
entrez: 26 5 2021
Statut: ppublish

Résumé

Mediator is an evolutionarily conserved multi-protein complex that mediates the interaction between different proteins as a basic linker in the transcription mechanism of eukaryotes. It interacts with RNA polymerase II and participates in the process of gene expression. Mediator complex subunit 19 or regulation by oxygen 3, or lung cancer metastasis-related protein 1 is located at the head of the mediator complex; it is a multi-protein co-activator that induces the transcription of RNA polymerase II by DNA transcription factors. It is a tumor-related gene that plays an important role in transcriptional regulation, cell proliferation, and apoptosis and is closely related to the occurrence and development of the cancers of the lung, bladder, skin, etc. Here, we used the structure of mediator complex subunit 19 to review its role in tumor progression, fat metabolism, drug therapy, as well as the novel coronavirus, which has attracted much attention at present, suggesting that mediator complex subunit 19 has broad application in the occurrence and development of clinical diseases. As a tumor-related gene, the role and mechanism of mediator complex subunit 19 in the regulation of tumor growth could be of great significance for the diagnosis, prognosis, and treatment of mediator complex subunit 19 -related tumors.

Identifiants

pubmed: 34038190
doi: 10.1177/15353702211011701
pmc: PMC8719036
doi:

Substances chimiques

MED19 protein, human 0
Mediator Complex 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1681-1687

Références

Cell Rep. 2020 Oct 6;33(1):108228
pubmed: 33027649
Mol Med Rep. 2012 Nov;6(5):1050-6
pubmed: 22961438
Gene. 2012 Aug 10;504(2):262-7
pubmed: 22565189
J Cell Mol Med. 2017 Dec;21(12):3254-3263
pubmed: 28631286
Mol Cell. 2016 Aug 4;63(3):539
pubmed: 27477911
Neoplasia. 2018 Dec;20(12):1209-1218
pubmed: 30412857
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Mol Cell Biochem. 2011 Sep;355(1-2):27-33
pubmed: 21519921
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
PeerJ. 2020 Jun 5;8:e9369
pubmed: 32547891
Cell. 2018 Nov 15;175(5):1289-1306.e20
pubmed: 30454647
J Biol Chem. 2020 Sep 25;295(39):13617-13629
pubmed: 32737196
Eur J Cancer. 2014 Apr;50(6):1125-36
pubmed: 24565852
Cell Death Dis. 2018 May 23;9(6):611
pubmed: 29795113
J Cell Biochem. 2019 Jan;120(1):507-518
pubmed: 30161287
Sci Rep. 2017 Mar 20;7:44662
pubmed: 28317934
Mol Cell. 2003 May;11(5):1301-9
pubmed: 12769853
Acta Pharmacol Sin. 2011 Mar;32(3):354-60
pubmed: 21372827
PLoS One. 2017 Jan 26;12(1):e0171134
pubmed: 28125713
Cell. 2016 Sep 8;166(6):1411-1422.e16
pubmed: 27610567
J Biol Chem. 2007 Feb 23;282(8):5551-9
pubmed: 17192271
PLoS Genet. 2014 May 01;10(5):e1004303
pubmed: 24786462
Ann Diagn Pathol. 2013 Jun;17(3):259-64
pubmed: 23276457
Curr Opin Cell Biol. 2012 Jun;24(3):305-13
pubmed: 22341791
Cell. 2020 May 14;181(4):832-847.e18
pubmed: 32304665
Br J Cancer. 2016 Nov 22;115(11):1367-1378
pubmed: 27811858
Cancer Lett. 2019 Mar 1;444:105-115
pubmed: 30583076
Annu Rev Biochem. 2000;69:729-49
pubmed: 10966474
J Exp Clin Cancer Res. 2011 Feb 09;30:18
pubmed: 21306606
Biochimie. 2019 Oct;165:1-8
pubmed: 31255603
J Med Virol. 2020 May;92(5):491-494
pubmed: 32056249
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6075-8
pubmed: 9177171
Baillieres Clin Haematol. 1992 Oct;5(4):857-79
pubmed: 1308167
Genes Dev. 2000 Nov 15;14(22):2906-17
pubmed: 11090137
Genome Res. 2013 Apr;23(4):581-91
pubmed: 23403032
Breast Cancer. 2017 May;24(3):433-441
pubmed: 27572702
Am J Transl Res. 2017 Feb 15;9(2):755-761
pubmed: 28337304
Int J Mol Med. 2012 Dec;30(6):1481-6
pubmed: 23076562
Asian Pac J Cancer Prev. 2015;16(3):875-80
pubmed: 25735376
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019
pubmed: 32141570
Cell Metab. 2020 Jan 7;31(1):148-161.e5
pubmed: 31761565
Mol Med Rep. 2017 Oct;16(4):4159-4164
pubmed: 28765911
Mol Cell Biol. 1991 Nov;11(11):5639-47
pubmed: 1656237
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Trends Mol Med. 2017 Jan;23(1):80-93
pubmed: 27989642
J Biol Chem. 2009 Jan 30;284(5):2648-2656
pubmed: 19049968
Onco Targets Ther. 2020 Nov 16;13:11711-11724
pubmed: 33235461
Nat Commun. 2020 Apr 24;11(1):2070
pubmed: 32332765
Genetics. 2006 Apr;172(4):2169-84
pubmed: 16452140
Science. 2005 Sep 16;309(5742):1864-8
pubmed: 16166518
Histol Histopathol. 2019 Nov;34(11):1279-1288
pubmed: 31066459
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
Genes Dev. 2001 Sep 15;15(18):2457-69
pubmed: 11562354
Biochem Biophys Res Commun. 2019 Jan 1;508(1):210-216
pubmed: 30473219
J Hepatol. 2020 Sep;73(3):603-615
pubmed: 32593682
BMB Rep. 2011 Aug;44(8):547-52
pubmed: 21871180
Oncogene. 2017 Aug 31;36(35):5084
pubmed: 28628117
Development. 2014 Mar;141(5):977-87
pubmed: 24550107
Nature. 2017 Nov 23;551(7681):427-431
pubmed: 29168817
Cancer Cell. 2019 May 13;35(5):798-815.e5
pubmed: 31031016
Trends Biochem Sci. 2005 May;30(5):264-71
pubmed: 15896745
Oncogene. 2019 May;38(20):3781-3793
pubmed: 30679790

Auteurs

Yuting Zhang (Y)

Department of Microbiology, Guilin Medical University, Guilin 541004, China.
Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541004, China.

Peifang Qin (P)

Department of Microbiology, Guilin Medical University, Guilin 541004, China.
Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541004, China.

Linlin Tian (L)

Department of Microbiology, Guilin Medical University, Guilin 541004, China.
Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541004, China.

Jianguo Yan (J)

Department of Physiology, Guilin Medical University, Guilin 541004, China.

Yali Zhou (Y)

Department of Microbiology, Guilin Medical University, Guilin 541004, China.
Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541004, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH